Interleukin 1a, Tumor Necrosis Factor a, and Interferon ? in Psoriasis
- 1 June 1991
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 127 (6) , 827-830
- https://doi.org/10.1001/archderm.1991.01680050071006
Abstract
• Although recent studies have suggested that a variety of cytokines released by keratinocytes and inflammatory leukocytes could contribute to induction or persistence of the inflammatory processes in psoriasis, it remains unclear how production of these cytokines is regulated in psoriatic patients. To elucidate the biologic relevance of these cytokines to the pathogenesis of psoriasis, we investigated serum levels of interleukin 1α, tumor necrosis factor α, and interferon γ in 21 patients with psoriasis vulgaris, together with 21 healthy controls. The mean serum levels of interleukin 1α and tumor necrosis factor α were not significantly different from those in controls, while those of interferon γ were significantly elevated in the patients with psoriasis. Serum levels of interleukin 1α correlated negatively with clinical disease severity expressed as psoriasis area and severity index score and with duration of psoriasis. In contrast, interferon γ levels were related, although not significantly, to disease severity. In addition, an inverse correlation was noted between the interleukin 1α levels and interferon γ levels. These results indicate that interleukin 1α and interferon γ may be relevant to the induction and perpetuation, respectively, of the inflammatory responses in psoriasis, and that these cytokines, which have similar biologic properties, may strictly regulate one another's production in vivo. (Arch Dermatol. 1991;127:827-830)Keywords
This publication has 6 references indexed in Scilit:
- In Situ Localization of Interleukin-1 in Normal and Psoriatic SkinJournal of Investigative Dermatology, 1989
- Psoriasis occurring predominantly on warts. Possible involvement of interferon alfaArchives of Dermatology, 1988
- SPECIFIC INTERLEUKIN-1 INHIBITOR IN SERUM AND URINE OF CHILDREN WITH SYSTEMIC JUVENILE CHRONIC ARTHRITISThe Lancet, 1987
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.Journal of Clinical Investigation, 1987
- There is more than one interleukin 1Immunology Today, 1986
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978